NCT03501589
Molecular Modulation of the Growth Plate
Enrolling by Invitation
Not specifiedAll AgesObservationalMayo ClinicInvestigator-initiated
~100 participants
Updated 2025-12-18 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
RNA expression
Measured over End of Study (1/2019
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- A. Noelle Larson, M.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Skeletally immature children/adults undergoing surgical procedures where growth plate cartilage is removed as a normal part of their procedure; or patients undergoing surgical procedures where bone is removed as a normal part of their procedure.
Exclusion
Skeletally mature children/adults
What this trial measures
- RNA expressionEnd of Study (1/2019
Measure RNA levels in growth plate tissue samples (ng/mL)